News Novartis drug gets fast US review in AML Midostaurin also under review in rare disease systemic mastocytosis
News Biogen/Ionis could launch rare disease drug within weeks Companies prepare for launch of Spinraza after phase 3 success.
Views & Analysis Tunnah’s musings: Rare diseases hold key to future of drug d... The lessons that can be learned for the future of drug development from the collaboration and innovation in this space.
Views & Analysis Every voice matters: demand assessment in rare diseases A market research approach suitable for the complexities found in rare diseases.
Views & Analysis Flexible models for better access Which initiatives are the most likely to bring life-changing therapies to patients?
Views & Analysis Digital Health Round-up – pharma to build Moonshot database,... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Adcendo raises $135m for cancer ADCs, and other financings Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
